Healthcare ❯ Pharmaceuticals

Obesity

Investigational Drugs GLP-1 Receptor Agonist GLP-1 Agonists Drug Pricing Clinical Research

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

The strategy concentrates resources on oral GLP-1 launches, reflecting rising analyst confidence in orforglipron.